Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.69T | 4.70T | 3.77T | 2.74T | 2.83T |
Gross Profit | 980.34B | 992.43B | 703.00B | 473.49B | 465.14B |
EBITDA | 727.82B | 693.58B | 511.04B | 318.05B | 310.41B |
Net Income | 338.06B | 385.08B | 200.43B | 70.01B | 76.51B |
Balance Sheet | |||||
Total Assets | 5.09T | 4.81T | 3.94T | 3.54T | 3.41T |
Cash, Cash Equivalents and Short-Term Investments | 1.96T | 1.92T | 1.37T | 1.13T | 1.14T |
Total Debt | 399.50B | 399.50B | 427.12B | 441.17B | 435.53B |
Total Liabilities | 2.37T | 2.25T | 1.83T | 1.64T | 1.63T |
Stockholders Equity | 2.71T | 2.56T | 2.10T | 1.89T | 1.78T |
Cash Flow | |||||
Free Cash Flow | 226.85B | 467.79B | 308.89B | 9.41B | 96.85B |
Operating Cash Flow | 492.14B | 767.66B | 503.76B | 195.65B | 289.38B |
Investing Cash Flow | -404.08B | -703.70B | -336.81B | -179.72B | -272.17B |
Financing Cash Flow | -187.32B | -66.47B | -122.31B | -98.50B | 13.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $14.74B | 7.17 | 11.75% | 2.63% | 1.62% | -20.55% | |
77 Outperform | $258.86B | 9.16 | 12.05% | 2.71% | 4.14% | -12.12% | |
77 Outperform | $54.58B | 11.95 | 5.17% | 3.96% | 1.68% | -39.28% | |
73 Outperform | $46.09B | 14.77 | 7.11% | 6.53% | 2.72% | -17.58% | |
72 Outperform | $54.33B | 9.05 | 7.07% | 0.90% | 5.34% | -28.29% | |
66 Neutral | $24.62B | 22.56 | 12.22% | ― | 10.28% | -29.75% | |
63 Neutral | €18.09B | 13.85 | 27.62% | 3.58% | -0.81% | -123.64% |